FDA

The Biosimilars Bill Checks Out — "Cuts Red Tape" Is a Fair Description of What FDA's Own Research Supports

Why this matters

Not every claim needs to reveal a gap. This one is included for completeness and because it involves a real regulatory tradeoff …